About Us

Print

My46 is an innovative web-based tool developed at the University of Washington by a team of clinical geneticists, genome scientists, genetic counselors, bioethicists, computer programmers, science educators, writers and illustrators. My46 enables individuals to manage their results from genetic testing, whether it is a single result being offered for return or the hundreds of results that can be offered for return from tests based on exome or whole genome sequencing.

  • Mission statement

    My46’s mission is to help individuals use genetic information to improve their health and well-being.

  • In the news  

    Dec. 24, 2012
    My46 highlighted in Time magazine article about using genomic information to make predictions about risk of disease.
    View Time article

    Nov. 10, 2012
    New project using My46 to return results from exome sequencing studies described in Nature news.
    View Nature article

  • Genetic results and policy  
    • Individuals should have the opportunity to receive results of genetic testing privately, inexpensively and at their convenience.

    • When more than one result is offered for return, individuals should be able to choose which results they want returned to them.

    • All individuals who receive genetic results should have the opportunity to speak with a genetics health professional (e.g., genetic counselor, clinical geneticist).

    • Parents should be offered for return all results available from genetic testing of their children.

Who We Are

  • Leadership team  

    Michael J. Bamshad, M.D.
    Mike is a Professor of Pediatrics and Genome Sciences, and Chief of the Division of Genetic Medicine at the University of Washington and Seattle Children’s Hospital. He is a co-founder of My46. Dr. Bamshad’s professional and research interests focus on understanding the origins and affinities of modern humans, developing novel strategies to find disease susceptibility variants, and characterizing genetic variants influencing risk for an assortment of health-related conditions. He and his colleagues were the first to use exome sequencing to identify genes for Mendelian and complex traits. He has published more than 150 papers in the field of human genetics. Dr. Bamshad earned a combined bachelor of the arts and medical degree from the University of Missouri at Kansas City and completed his residency, clinical genetics fellowship, and post-doctoral training at the University of Utah.


    Holly K. Tabor, Ph.D.
    Holly is an Assistant Professor of Pediatrics in the Division of Bioethics at the University of Washington and at the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute. She is a co-founder of My46. Dr. Tabor’s professional and research interests include ethical issues in genetic research, particularly those related to informed consent, data sharing, and return of results from exome and whole genome sequencing studies. She earned a Ph.D. in epidemiology and genetics and completed a post-doctoral fellowship in ethics, both at Stanford University.


  • Development team  

    Michael J. Bamshad, M.D.
    Mike is a Professor of Pediatrics and Genome Sciences, and Chief of the Division of Genetic Medicine at the University of Washington and Seattle Children’s Hospital. He is a co-founder of My46. Dr. Bamshad’s professional and research interests focus on understanding the origins and affinities of modern humans, developing novel strategies to find disease susceptibility variants, and characterizing genetic variants influencing risk for an assortment of health-related conditions. He and his colleagues were the first to use exome sequencing to identify genes for Mendelian and complex traits. He has published more than 150 papers in the field of human genetics. Dr. Bamshad earned a combined bachelor of the arts and medical degree from the University of Missouri at Kansas City and completed his residency, clinical genetics fellowship, and post-doctoral training at the University of Utah.


    Holly K. Tabor, Ph.D.
    Holly is an Assistant Professor of Pediatrics in the Division of Bioethics at the University of Washington and at the Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute. She is a co-founder of My46. Dr. Tabor’s professional and research interests include ethical issues in genetic research, particularly those related to informed consent, data sharing, and return of results from exome and whole genome sequencing studies. She earned a Ph.D. in epidemiology and genetics and completed a post-doctoral fellowship in ethics, both at Stanford University.


    Joon-Ho Yu, M.P.H., Ph.D.
    Joon is a post-doctoral researcher in the Department of Pediatrics at the University of Washington. His research interests include developing and studying culturally tailored strategies for returning genetic results from exome and whole genome sequencing through My46. He earned a Ph.D. and M.P.H. in Public Health Genetics at the University of Washington where his training focused on genetic epidemiology, bioethics, and anthropology.


    Seema Jamal, M.Sc., CGC
    Seema is a licensed and certified genetic counselor in the Division of Genetic Medicine of the Department of Pediatrics at the University of Washington. She joined the My46 team in 2012 after spending the past seven years as a clinical genetic counselor at Boston University Medical Center. She earned a M.Sc. degree in Genetic Counselling from the University of Toronto.


    Karin Dent, M.S., CGC
    Karin is a licensed and certified genetic counselor and Assistant Professor in the Division of Medical Genetics of the Department of Pediatrics at the University of Utah. She is a past president of the National Society of Genetic Counselors and Associate Director of the University of Utah Graduate Program in Genetic Counseling. She earned a M.S. degree in Human Genetics and Genetic Counseling from the University of Pittsburgh.


    Julia Crouch, M.P.H.
    Research Associate, Treuman Katz Center for Pediatric Bioethics at Seattle Children’s Research Institute


    Margaret McMillin, B.S.
    Clinical Research Coordinator, Division of Genetic Medicine at the University of Washington


    Aditi Shankar, B.A.
    Clinical Research Coordinator, Division of Genetic Medicine at the University of Washington


  • Advisory team  

    Michael Astion, M.D., Ph.D.
    Mike is a Clinical Professor of Laboratory Medicine and Division Chief of Laboratory Medicine at Seattle Children’s Hospital. Dr. Astion’s professional and research interests focus on laboratory utilization management, laboratory errors and patient safety, and medical informatics. He has published more than 30 papers in the field of laboratory medicine. Dr. Astion received his M.D. and Ph.D. degrees from the University of Pennsylvania, and completed his residency training at the University of Pennsylvania and the University of Washington.


    Peter H. Byers, M.D.
    Peter is a Professor of Pathology and Medicine, Adjunct Professor of Genome Sciences, and the Director of the Collagen Diagnostic Laboratory at the University of Washington. As an attending physician at the University of Washington Medical Center Genetic Medicine Clinic, Dr. Byers sees patients and families with suspected connective tissue disorders. His research interests include studying the biochemical and molecular basis of heritable connective tissue disorders, particularly forms of Osteogenesis Imperfecta and Ehlers-Danlos syndromes. Dr. Byers received his medical degree from Case Western Reserve University School of Medicine.


    Deborah Nickerson, Ph.D.
    Debbie is a Professor of Genome Sciences and Adjunct Professor of Bioengineering at the University of Washington. She is the leader of the Northwest Genomics Center, one of two large sequencing centers in the country. Dr. Nickerson’s professional and research interests focus on the identification and typing of common sequence variations in the human genome in an effort to improve approaches for association mapping of common human diseases. She and her colleagues are exploring the genetics of cardiovascular disease, developing and testing novel approaches for association mapping, and exploring the relationships that may exist between genotype and trait expression at the RNA and protein levels in humans. Dr. Nickerson received her Ph.D. from the University of Tennessee.


    Charmaine D. Royal, Ph.D.
    Charmaine is an Associate Research Professor in the Institute for Genome Sciences & Policy, and the Department of African & African American Studies at Duke University. Her professional and research interests focus on the ethical, psychosocial, and societal issues at the intersection of genetics and genomics. Dr. Royal earned an M.S. in Genetic Counseling and a Ph.D. in Human Genetics from Howard University. She completed her postgraduate training in bioethics and ELSI (ethical, legal, and social implications) research at the National Human Genome Research Institute of the National Institutes of Health, and in epidemiology and behavioral medicine at the Howard University Cancer Center.

  • Contributors  

    Alizabeth Woodruff
    Allison Cirino, MS, LCGC
    Allison Gregory, MS, CGC
    Ana Morales, MS, CGC
    Andrea Shugar, MS, CGC
    Angela Trepanier, MS, CGC
    Brenda Finucane, MS, CGC
    Briana Lauren Sawyer, MS, LCGC
    Carly Siskind, MS, MS, CGC
    Carmelina Heydrich, MS
    Cheryl Shuman, MS, CGC
    Christie Turcott, MS, CGC
    Corrie Smith, MS, LCGC
    Courtney Berrios, ScM, CGC
    Dan Doherty, MD
    Darci Sternen, MS, LGC
    Dawn Laney, MS, CGC
    Deanna Steele, MS, CGC
    Dianne Daughtery (MHAUS Executive Director)
    Edye Conway, MS, CGC
    Elicia Estrella, MS, LCGC
    Gretchen Oswald, MS, CGC
    Heather MacLeod, MS, CGC
    Jamie McDonald, MS, LCGC
    Jeanie Schaller, MS, CGC
    Jennifer Boomsma, MS, CGC
    Jennifer Dempsey, MPH
    Jennifer Farmer, MS, CGC
    Jennifer Propst, MS, CGC
    Jennifer Walsh, MS, CGC
    Jessica Waxler, MS, CGC
    Jill Goldman, MS, MPhil, CGC
    Jilliane Sotelo, MS, LCGC
    Joline Dalton, MS, CGC
    Joy Larsen Haidle, MS
    Julie Mak, MS, MSc, LCGC
    Kami Wolfe Schneider, MS, CGC
    Karen Metzler, MS, CGC
    Kari Branham, MS, CGC
    Karin Dent, MS, LCGC
    Kate Orland, MS, CGC
    Katie Golden-Grant, MS, LCGC
    Kenneth Huttner, MD
    Kira Dies, ScM, LCGC
    Kory Jasperson, MS, CGC
    Kristin Maloney, MS, MGC
    Kristin Zelley, MS, CGC
    Lakshmi Warrier, MS, CGC
    Laura Conway, PhD, CGC
    Laura Fisher, MS
    Lauren Ryan, MS, LCGC
    Laura Zahavich, MSc, CGC
    Lindsay Meyers, MS, LCGC
    Lisa Kinsley, MS, LCGC
    Maureen Flynn, MS, LCGC, MPH
    Meadow Heiman, MS, CGC
    Meg Hefner, MS, CGC
    Megan Myers, MS
    Megan Tucker, MS, LGC
    Melanie Pepin, MS, LCGC
    Melissa Fuller, MS, CGC
    Nisha Isaac, MS, CGC
    Rebecca McClellan, MGC, CGC
    Robert L. Nussbaum, MD
    Robert Pilarski, MS, CGC
    Rosanna Weksberg, MD, PhD
    Sanaa Choufani, PhD
    Sarah Richards, MS
    Seema Jamal, MSc, LCGC
    Stephanie Cagle, MS, CGC
    Stephanie Newton, MS, LCGC
    Stephanie Stein, MD
    Tanya Eble, MS, CGC
    Tara Newcomb, MS, CGC
    Tessa Field
    Toni Pollin, MS, PhD, CGC
    Tomi Toler, MS, CGC
    Valynne Long, MS, CGC
    Victoria Duke, MS

My46 is an innovative web-based tool that enables individuals to manage their own genetic testing results.

Your genome is your entire genetic code or all of the DNA in a cell.

What My46 Means

Most human cells have 46 chromosomes that provide the genetic instructions for a body to live, grow, and develop.

Your Session Is About to Expire

To keep your account secure, your My46 session expires after one hour of inactivity. If you are still using the site, click below to extend your session.